Arthur C. Butcher - Aug 21, 2023 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role
EVP& Grp Pres, MedSurg & APAC
Signature
/s/ Susan Thompson, Attorney-in-Fact
Stock symbol
BSX
Transactions as of
Aug 21, 2023
Transactions value $
-$332,661
Form type
4
Date filed
8/22/2023, 05:09 PM
Previous filing
Jun 22, 2023
Next filing
Nov 21, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSX Common Stock Sale -$333K -6.6K -36.67% $50.40 11.4K Aug 21, 2023 Direct F1, F2, F3
holding BSX Common Stock 2.54K Aug 21, 2023 By 401(k) F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction reported in this Form 4 was effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 21, 2023, intended to comply with the prior version of Rule 10b5-1(c).
F2 Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $50.26 to $50.54, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3 Includes shares acquired on June 30, 2023 under the Boston Scientific Employee Stock Purchase Plan based upon the most current data available.
F4 Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.